{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:36:58Z","timestamp":1775522218845,"version":"3.50.1"},"reference-count":32,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2009,7,6]],"date-time":"2009-07-06T00:00:00Z","timestamp":1246838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> The absence of a gold standard test for <jats:italic>Trypanosoma cruzi<\/jats:italic> antibodies represents a problem not only for the evaluation of screening tests, but also for appropriate blood donor counseling. The aim of this study was to estimate the sensitivity and specificity of multiple blood donor screening tests for <jats:italic>T. cruzi<\/jats:italic> antibodies in Argentina.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> From June 2006 to March 2007 a sample of 1455 blood donors was recruited from two blood banks in Chaco province, an area of Argentina with highly endemic <jats:italic>T. cruzi<\/jats:italic> infection. Samples were tested by three epimastigote lysate enzyme immunoassays (EIAs), one recombinant antigen EIA, two indirect hemagglutination assay (IHA) tests, a particle agglutination assay (PA), and a research <jats:italic>trans<\/jats:italic>\u2010sialidase inhibition assay (TIA). Sensitivity and specificity were estimated using latent class analysis (LCA).<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> LCA estimated the consensus prevalence of <jats:italic>T. cruzi<\/jats:italic> infection at 24.5%. Interassay correlation was higher among the four EIA tests and TIA compared to IHA tests. Assay sensitivities varied from 96 to 99.7 for different EIAs, 91% for TIA, 84% for PA, and 66 to 74% for IHA tests. Relative to the LCA, assay specificities were from 96% to almost 100%.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> Based on the comparison of several tests in a large population from an endemic area for <jats:italic>T. cruzi<\/jats:italic> infection, our data showed an adequate sensitivity for EIA tests in contrast to PA and IHA assays. The latter tests should no longer be used for blood donor screening.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2009.02301.x","type":"journal-article","created":{"date-parts":[[2009,7,7]],"date-time":"2009-07-07T00:52:28Z","timestamp":1246927948000},"page":"2352-2358","source":"Crossref","is-referenced-by-count":30,"title":["Estimation of sensitivity and specificity of several <i>Trypanosoma cruzi<\/i> antibody assays in blood donors in Argentina"],"prefix":"10.1111","volume":"49","author":[{"given":"Mirta C.","family":"Remesar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Gamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana F.","family":"Colaianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Puppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula A.","family":"Sartor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward L.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten B.","family":"Neilands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda A.","family":"Ridolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Susana","family":"Leguizam\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvina","family":"Kuperman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana E.","family":"Del Pozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,22]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762003000500001"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0700863104"},{"key":"e_1_2_8_4_2","first-page":"125","article-title":"Seroprevalence of Chagas disease in 17 rural communities of \u201cMonte Impenetrable\u201d, Chaco Province","volume":"63","author":"Biancardi MA","year":"2003","journal-title":"Medicina (B Aires)"},{"key":"e_1_2_8_5_2","first-page":"141","article-title":"Blood donor screening for chagas disease\u2014United States, 2006\u20102007","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00077.x"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01068.x"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/527448"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(00)00168-6"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/48.4.515"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg338"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00279.x"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4922(01)01897-9"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.6.1570"},{"key":"e_1_2_8_15_2","first-page":"1","article-title":"Control of Chagas disease: second report of the WHO expert committee","volume":"905","author":"WHO","year":"2002","journal-title":"WHO Tech Rep Ser"},{"key":"e_1_2_8_16_2","first-page":"1","article-title":"Control of Chagas disease: report of a WHO expert committee","volume":"811","author":"WHO","year":"1991","journal-title":"WHO Tech Rep Ser"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40091048.x"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.2006.00703.x"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00127-07"},{"key":"e_1_2_8_20_2","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1128\/JCM.36.9.2423-2427.1998","article-title":"Evaluation of three commercial enzyme\u2010linked immunosorbent assays for diagnosis of Chagas' disease","volume":"36","author":"Oelemann WM","year":"1998","journal-title":"J Clin Microbiol"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-1732"},{"key":"e_1_2_8_22_2","first-page":"703","article-title":"Medium scale production and purification to homogeneity of a recombinant trans\u2010sialidase from Trypanosoma cruzi","volume":"42","author":"Buschiazzo A","year":"1996","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/593697"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.2.639-642.2000"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1179\/136485906X112248"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2003.00340.x"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.8.1.187-189.2001"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780090509"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.2307\/2533555"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2005.04214.x"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00490.x"},{"key":"e_1_2_8_32_2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1128\/CDLI.5.2.254-255.1998","article-title":"Use of trans\u2010Sialidase inhibition assay in a population serologically negative for Trypanosoma cruzi but at a high risk of infection","volume":"5","author":"Leguizamon MS","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/590159"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2009.02301.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2009.02301.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T05:05:49Z","timestamp":1697259949000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2009.02301.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,22]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1111\/j.1537-2995.2009.02301.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2009.02301.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,22]]}}}